transplant rejection
Oncocyte Enters $29.1M Securities Purchase Agreement
The company expects the funds to be sufficient to complete development of its IVD diagnostic transplant assay program.
Israeli Liquid Biopsy Startup Senseera Raises $7.1M in Seed Round
The funding will help the company commercialize a blood-based liver transplant rejection test as it continues to push for its platform in other disease research.
Oncocyte Kidney Transplant Test Receives Expanded Medicare Coverage
The test can be used to monitor kidney transplant patients with newly developed donor-specific antibodies for antibody-mediated rejection.
Natera Prospera Lung Test Receives Medicare Coverage for Single Lung Transplant Patients
The test was launched in 2022 and received coverage for double-lung transplant patients in 2023.
CareDx Raises Full-Year Guidance as Q3 Revenues Grow 23 Percent
Quarterly revenue gains were driven by a 27 percent year-over-year increase in testing services revenue.
Jan 3, 2024
Nov 9, 2023